Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports – Reuters

Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports  Reuters

Leave a Reply

Your email address will not be published. Required fields are marked *